Malgorzata Wygrecka Selected Research

Insulin-Like Peptides

1/2022

Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Malgorzata Wygrecka Research Topics

Disease

25	Inflammation (Inflammations) 04/2024 - 10/2007
19	Idiopathic Pulmonary Fibrosis 01/2023 - 09/2008
18	Fibrosis (Cirrhosis) 04/2024 - 12/2008
11	Neoplasms (Cancer) 01/2021 - 03/2010
10	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 07/2007
10	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 09/2012
9	Pulmonary Hypertension 11/2023 - 09/2008
8	Lung Injury 04/2024 - 03/2008
6	Familial Primary Pulmonary Hypertension 01/2019 - 09/2008
5	Infections 04/2024 - 08/2008
5	Pneumonia (Pneumonitis) 01/2023 - 07/2007
5	Acute Lung Injury 12/2022 - 07/2007
5	Interstitial Lung Diseases (Interstitial Lung Disease) 10/2022 - 03/2008
5	Hypoxia (Hypoxemia) 01/2019 - 09/2008
4	Lung Diseases (Lung Disease) 01/2023 - 09/2004
3	Lung Neoplasms (Lung Cancer) 01/2023 - 03/2010
3	Glioma (Gliomas) 11/2018 - 01/2017
2	Communicable Diseases (Infectious Diseases) 04/2024 - 11/2016
2	Asthma (Bronchial Asthma) 01/2023 - 09/2012
2	COVID-19 01/2023 - 01/2022
2	Edema (Dropsy) 12/2022 - 03/2012
2	Systemic Scleroderma (Systemic Sclerosis) 10/2022 - 01/2021
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2021 - 02/2009
2	Carcinogenesis 01/2021 - 03/2010
2	Kidney Diseases (Kidney Disease) 01/2021 - 01/2019
2	Sarcoidosis (Schaumann Disease) 01/2021 - 02/2009
2	Reperfusion Injury 01/2019 - 01/2019
2	Chronic Obstructive Pulmonary Disease (COPD) 03/2014 - 09/2012
2	Vascular Remodeling 03/2014 - 04/2012
1	Thrombosis (Thrombus) 04/2024
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023

Drug/Important Bio-Agent (IBA)

12	Bleomycin (Blenoxane)FDA LinkGeneric 04/2024 - 02/2009
10	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2007
10	BiglycanIBA 01/2021 - 10/2017
6	FibrinIBA 04/2024 - 09/2004
6	Peptide Hydrolases (Proteases)FDA Link 08/2013 - 06/2007
5	CollagenIBA 11/2023 - 11/2018
5	pirfenidoneIBA 10/2022 - 01/2017
5	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 01/2018
4	RNA (Ribonucleic Acid)IBA 01/2023 - 07/2007
4	Small Leucine-Rich ProteoglycansIBA 01/2021 - 01/2018
4	Factor VII (Proconvertin)IBA 03/2008 - 06/2007
3	Hyaluronic Acid (Hyaluronan)IBA 12/2022 - 10/2017
3	Factor XII (Hageman Factor)IBA 01/2022 - 04/2010
3	DecorinIBA 01/2021 - 01/2018
3	Cell Surface ReceptorsIBA 01/2021 - 11/2012
3	Proteoglycans (Proteoglycan)IBA 01/2021 - 01/2019
3	indium-bleomycinIBA 07/2020 - 09/2008
3	MonocrotalineIBA 01/2019 - 09/2008
3	Histones (Histone)IBA 01/2019 - 09/2012
2	Fibrinogen (Factor I)FDA Link 01/2023 - 01/2022
2	Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA 11/2022 - 01/2017
2	Plasminogen Activators (Plasminogen Activator)IBA 01/2022 - 07/2007
2	LigandsIBA 01/2022 - 12/2012
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2018
2	Plasminogen Activator Inhibitor 1IBA 01/2020 - 07/2007
2	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 05/2018 - 12/2015
2	Transcription Factors (Transcription Factor)IBA 04/2018 - 09/2008
2	InflammasomesIBA 01/2018 - 01/2018
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 08/2011
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017 - 02/2007
2	Fibrinolysin FDA Link 05/2015 - 11/2014
2	Chymases (Chymase)IBA 03/2014 - 01/2013
2	Proteinase-Activated ReceptorsIBA 08/2013 - 06/2011
2	Oxygen (Dioxygen)IBA 01/2013 - 02/2007
2	Thromboplastin (Tissue Factor)IBA 11/2012 - 06/2011
2	Becaplermin (PDGF-BB)FDA Link 04/2012 - 06/2007
2	Factor VIIa (Activated Factor VII)IBA 06/2011 - 03/2008
2	Heparin (Liquaemin)FDA LinkGeneric 06/2010 - 03/2008
2	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 03/2010 - 12/2008
2	Surface-Active Agents (Surfactants)IBA 12/2008 - 07/2007
2	Pulmonary Surfactants (Pulmonary Surfactant)IBA 07/2007 - 07/2007
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2024
1	AcrylamidesIBA 12/2023
1	PAR-2 ReceptorIBA 12/2023
1	Small Interfering RNA (siRNA)IBA 12/2023
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2023
1	SpermineIBA 12/2023
1	Peptides (Polypeptides)IBA 11/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	cadherin 5IBA 01/2023
1	PolyubiquitinIBA 01/2023
1	OvalbuminIBA 01/2023
1	CholesterolIBA 01/2023
1	Carrier Proteins (Binding Protein)IBA 01/2023
1	IntegrinsIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	SmokeIBA 01/2023
1	NF-kappa B (NF-kB)IBA 01/2023
1	InterleukinsIBA 01/2023
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2023
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2023
1	EndostatinsIBA 01/2023
1	ExotoxinsIBA 12/2022
1	Blood Proteins (Serum Proteins)IBA 12/2022
1	E-SelectinIBA 12/2022
1	Streptococcus pneumoniae plY proteinIBA 12/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2022

Therapy/Procedure

7	Therapeutics 01/2023 - 02/2007